Bradford Perez, MD
Dr. Bradford Perez is a radiation oncologist with Florida Cancer Specialists & Research Institute, practicing at the FCS Trinity Cancer Center in Pasco County, Florida. He specializes in lung cancer, mesothelioma, thymoma, and other thoracic malignancies. He uses advanced technologies, including image-guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT), and intensity-modulated radiation therapy (IMRT) for patients seeking curative and palliative solutions.[1]
Education and Career
Dr. Perez earned a Bachelor of Science degree from Georgetown University before moving on to Duke University School of Medicine for his medical degree. He spent the next several years at the Duke University Health System and School of Medicine, where he completed an internship in Internal Medicine and a residency in Radiation Oncology.[1]
After his tenure at Duke, Dr. Perez moved on to the Moffitt Cancer Center, where he was an Associate Member of the Radiation Oncology Department.
Dr. Perez is now a radiation oncologist with the Florida Cancer Specialists & Research Institute. He specializes in treating thoracic cancers, breast cancer, prostate cancer, and other cancers using advanced radiation therapies.
Dr. Perez is particularly interested in improving patient outcomes by combining radiation therapy’s most innovative tools with novel systemic agents, such as immunotherapeutics and targeted therapies. He and his colleagues from diverse disciplines meet to discuss each patient’s unique genetic footprint to determine the most advantageous combination of radiation therapy and other protocols.
While attending Duke University School of Medicine, Dr. Perez exposed a research scandal involving the use of fraudulent genomic data. While his warning was initially ignored, the clinical trials were eventually closed, and his whistleblowing memo became important evidence exposing wrongdoing.[2]
Research
Dr. Perez is currently an active participant in a clinical trial investigating the use of genomically guided radiation dose personalization in the management of locally advanced non-small cell lung cancer.
He has been involved in numerous studies that have been published in respected medical journals, including the International Journal of Radiation Oncology, Biology, and Physics; Radiotherapy and Oncology; Journal of Clinical Oncology; The Journal of Immunology; and the Journal of Thoracic Oncology.[1]
